|Bid||122.00 x 900|
|Ask||122.52 x 800|
|Day's Range||122.06 - 124.69|
|52 Week Range||98.94 - 135.89|
|Beta (5Y Monthly)||0.81|
|PE Ratio (TTM)||46.05|
|Earnings Date||Nov 23, 2021|
|Forward Dividend & Yield||2.52 (1.94%)|
|Ex-Dividend Date||Sep 23, 2021|
|1y Target Est||145.56|
The Zacks Analyst Blog Highlights: Disney, Intel, Medtronic, Target and Deere
Today's Research Daily features new research reports on 16 major stocks, including The Walt Disney Company (DIS), Intel Corporation (INTC), and Medtronic plc (MDT).
With that in mind, let's turn our attention to two healthcare giants with excellent track records -- Medtronic (NYSE: MDT) and Novo Nordisk (NYSE: NVO) -- and see why both companies may be well worth holding onto for the years ahead. Like many other medical-device specialists, Medtronic had a rough go of it at the peak of the pandemic. Healthcare facilities swamped with COVID-19 patients postponed elective surgeries, leading to lower sales volume for some of Medtronic's products used by physicians.